top border
top border
Featured Programs

Treatment Goals in Refractory mCRC
Tanios Bekaii-Saab, MD, FACP, Andrea Cercek, MD, and Zev A. Wainberg, MD, provide insight to the treatment goals for patients with refractory metastatic colorectal cancer.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer

Recent advances in the treatment of metastatic colorectal cancer (mCRC) have improved survival. However, many questions remain. Led by John L. Marshall, MD, panelists Tanios Bekaii-Saab, MD; Johanna Bendell, MD; Richard Kim, MD; and Charles S. Fuchs, MD, MPH, discuss strategies and approaches to managing mCRC, including the latest research and how it may influence clinical practice.

View Now

Featured Webinar
HCC

Join us for a live broadcast on Wednesday May 27, 2020 at 5 PM PST and 6 PM PST and June 17, 2020 at 5 PM PST and 8 PM PST. View more


FDA Approvals in HCC and Cervical Cancer, Breakthrough Designation in Lung Cancer, and More

Gina ColumbusGina Columbus recaps on the latest news in oncology.

Publication Bottom Border
Border Publication
x